Investments
78Portfolio Exits
6Funds
7Service Providers
1About Rosecliff Ventures
Rosecliff Ventures is a venture capital firm investing in startup enterprises and innovative ideas that have substantial growth potential. The firm's goal is to invest in dynamic founders and help them realize their dreams. Rosecliff will seek to invest predominately in early stage venture opportunities.

Want to inform investors similar to Rosecliff Ventures about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Rosecliff Ventures News
May 30, 2023
Lifeforce – which is the first comprehensive and clinically integrated health optimization platform – announced the closing of its $12 million Series A funding round co-led by M13 and Peterson Ventures. The oversubscribed funding round also includes participation by Ridgeline Ventures, Rosecliff Ventures, and Seaside Ventures. In a fragmented healthcare market, Lifeforce is operating as the trusted partner for people seeking to take proactive control of their health by bringing together the biomarker data, clinical expertise, and validated interventions needed to optimize health and longevity. This company was incubated by M13’s in-house venture studio Launchpad – which has built multiple businesses in the health and wellness space. And the company is additionally backed by some of the most influential figures in health and human performance including renowned author and Lifeforce Co-Founder Tony Robbins; technologist, physician, engineer, and Lifeforce Co-Founder Dr. Peter Diamandis; and professional tennis legend Serena Williams. Using a convenient telehealth-driven model, Lifeforce lowers cost, reduces friction, and makes personalized health optimization more accessible. And members receive regular in-home diagnostic blood tests from registered phlebotomists who are covering the 40-plus biomarkers most important to physical, cognitive, sexual, and psychological performance. The results are then interpreted by a team of trained medical doctors to create a personalized program of scientifically validated lifestyle adjustments, nutraceuticals, and hormone and peptide therapies customized to each member’s biology and goals. And unlike most other longevity platforms, members also have direct ongoing access to specialized clinicians and health coaches and are re-tested every three months to track progress and refine programs accordingly. Lifeforce’s model was developed with the guidance of an expert Advisory Board including Dr. Mark Hyman, Head of Strategy and Innovation of the Cleveland Clinic Center for Functional Medicine; Dr. Fatima Cody Stanford, Weight Management Expert and Associate professor at Harvard Medical School; Dr. Rudy Tanzi, Harvard Medical School Vice-Chair of Neurology and Massachusetts General Hospital Director and Dr. Kathryn Rexrode, Chief of the Division of Women’s Health in the Department of Medicine at Brigham and Women’s Hospital (BWH) and a Professor of Medicine at Harvard Medical School. At a fraction of the cost of other offerings, a Lifeforce membership has a starting price of $349 for an initial baseline assessment and $129 per month for membership thereafter. What the funding will be used for: This latest round of financing enables Lifeforce to accelerate growth, expand its offering, and cement its position as the world’s leading health optimization platform. And the company is also working on data tools that will allow it to further improve the efficacy of its personalized programs while lowering costs. KEY QUOTES: “No one should have to settle for feeling average as they age. People want a convenient solution for functioning at their best, and the peace of mind that they are on the right track to live a long and healthy life. Eighty-five percent of Lifeforce members report improved quality of life within the first three months of being on a Lifeforce program. We analyze key biomarkers to find out where people are sub-optimal and close those gaps so they can feel stronger, think clearer, and live longer.” — Dugal Bain-Kim, co-founder and CEO of Lifeforce “I’ve spent 35 years helping people unlock their potential. Over that time I’ve learned that if you’re not in the driver’s seat of your health, you’re not going to be your most powerful self. So much more is possible in life when you decide to be proactive and assert yourself as the CEO of your own health. We launched Lifeforce to make it easier for people to do that.” — Tony Robbins, Co-Founder, Lifeforce “Lifeforce is poised to have a transformative impact, not just redefining the health optimization category but the very way we think about what’s possible as we age. Demand for personalized proactive healthcare is growing exponentially and the team’s collective expertise in health, technology, and business uniquely positions Lifeforce to meet this demand.” — Courtney Reum, Lifeforce Board Chairman and Co-founder at M13 “Lifeforce is a comprehensive, convenient platform that takes the guesswork out of balancing hormones, nutrients, metabolism, and organ health so we not only live longer but live better.” — Mark Hyman, MD, Lifeforce Advisor Trending on Pulse 2.0
Rosecliff Ventures Investments
78 Investments
Rosecliff Ventures has made 78 investments. Their latest investment was in Lifeforce as part of their Series A on May 5, 2023.

Rosecliff Ventures Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
5/23/2023 | Series A | Lifeforce | $12M | Yes | 3 | |
1/3/2023 | Series E | Anokiwave | $4.79M | Yes | 1 | |
7/28/2022 | Seed VC | Revolv3 | $4.5M | Yes | Rosecliff Ventures, and Undisclosed Angel Investors | 3 |
2/7/2022 | Series A | |||||
12/6/2021 | Seed VC - II |
Date | 5/23/2023 | 1/3/2023 | 7/28/2022 | 2/7/2022 | 12/6/2021 |
---|---|---|---|---|---|
Round | Series A | Series E | Seed VC | Series A | Seed VC - II |
Company | Lifeforce | Anokiwave | Revolv3 | ||
Amount | $12M | $4.79M | $4.5M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | Rosecliff Ventures, and Undisclosed Angel Investors | ||||
Sources | 3 | 1 | 3 |
Rosecliff Ventures Portfolio Exits
6 Portfolio Exits
Rosecliff Ventures has 6 portfolio exits. Their latest portfolio exit was Gatsby on August 17, 2022.
Rosecliff Ventures Fund History
7 Fund Histories
Rosecliff Ventures has 7 funds, including Rosecliff Credit Opportunity Fund I.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
6/29/2020 | Rosecliff Credit Opportunity Fund I | $150M | 1 | ||
3/31/2019 | Rosecliff Venture Partners IV | ||||
12/31/2018 | Rosecliff Venture Partners III | ||||
6/20/2018 | Rosecliff Venture Partners II | ||||
11/14/2016 | Rosecliff Venture Partners |
Closing Date | 6/29/2020 | 3/31/2019 | 12/31/2018 | 6/20/2018 | 11/14/2016 |
---|---|---|---|---|---|
Fund | Rosecliff Credit Opportunity Fund I | Rosecliff Venture Partners IV | Rosecliff Venture Partners III | Rosecliff Venture Partners II | Rosecliff Venture Partners |
Fund Type | |||||
Status | |||||
Amount | $150M | ||||
Sources | 1 |
Rosecliff Ventures Service Providers
1 Service Provider
Rosecliff Ventures has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel | General Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource